Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
5.29
-0.45 (-7.84%)
At close: May 30, 2025, 4:00 PM
5.27
-0.02 (-0.38%)
After-hours: May 30, 2025, 7:57 PM EDT
Aligos Therapeutics Revenue
Aligos Therapeutics had revenue of $311.00K in the quarter ending March 31, 2025, a decrease of -68.46%. This brings the company's revenue in the last twelve months to $3.27M, down -76.29% year-over-year. In the year 2024, Aligos Therapeutics had annual revenue of $3.95M, down -74.60%.
Revenue (ttm)
$3.27M
Revenue Growth
-76.29%
P/S Ratio
11.01
Revenue / Employee
$46,714
Employees
70
Market Cap
32.35M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
ALGS News
- 2 days ago - Aligos Therapeutics to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 11 days ago - Aligos Therapeutics Appoints Laura Kavanaugh as Vice President, Head of Legal - GlobeNewsWire
- 15 days ago - Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 23 days ago - Aligos Therapeutics Presents Positive Data at the EASL Congress 2025 - GlobeNewsWire
- 25 days ago - Aligos Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results - GlobeNewsWire
- 4 weeks ago - Aligos Therapeutics to Announce 1st Quarter 2025 Financial Results on May 6, 2025 - GlobeNewsWire
- 5 weeks ago - Aligos Therapeutics Announces Eight Abstracts Accepted for Presentation at the EASL Congress 2025 - GlobeNewsWire
- 2 months ago - Aligos Therapeutics Presents Positive Data at APASL 2025 - GlobeNewsWire